Type 1 diabetes, Chronic kidney disease
Conditions
Interventions
use artificial pancreas for the perioperative period of the pancreas transplant
Sponsors
Fujita Health University HospitalDepartment of Organ Transplant Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The pancreas transplant that is enforced in our hospital which was able to get an agreement
Exclusion criteria
Exclusion criteria: subject is otherwise considered ineligible for the study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glucose tolerance accessed by OGTT one month after transplantation | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood flow velocity and resistance accessed by CEUS , morbidity, Days of ICU stay, Days of hospitalization | — |
Countries
Japan
Contacts
Public ContactTaihei Ito
Fujita Health University Hospital Department of Organ Transplant Surgery
Outcome results
None listed